It doesn't matter if we like your view or not, nor will your view or mine, change the direction of the company.
The biggest problem with you argument is how do you finance ongoing exploration?
Endless capital raisings into falling share prices?
Too many juniors seem to be getting decimated lately because of exactly that.
That can’t be what the market wants.
If we move to production next year while we still have cash, we will be able to heavily accelerate exploration expenditure through cash flow without the dilution.
I’m very happy that that is the direction management have chosen.
By far the best direction in this market IMO.
- Forums
- ASX - By Stock
- chart
It doesn't matter if we like your view or not, nor will your...
Featured News
Add PRX (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.350M |
Open | High | Low | Value | Volume |
0.3¢ | 0.3¢ | 0.2¢ | $193 | 71.66K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
33 | 80951376 | 0.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.3¢ | 90078809 | 46 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
33 | 80951376 | 0.002 |
61 | 148486436 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.003 | 87778809 | 45 |
0.004 | 17407006 | 16 |
0.005 | 4992123 | 6 |
0.006 | 5100002 | 5 |
0.007 | 4617000 | 4 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
PRX (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online